CN106676153A - Preparation method and application of meretrix lusoria blood-pressure-reducing peptide - Google Patents
Preparation method and application of meretrix lusoria blood-pressure-reducing peptide Download PDFInfo
- Publication number
- CN106676153A CN106676153A CN201611021249.6A CN201611021249A CN106676153A CN 106676153 A CN106676153 A CN 106676153A CN 201611021249 A CN201611021249 A CN 201611021249A CN 106676153 A CN106676153 A CN 106676153A
- Authority
- CN
- China
- Prior art keywords
- parts
- clam
- weight
- preparation
- meat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 101
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 241001262060 Meretrix lusoria Species 0.000 title 1
- 235000013372 meat Nutrition 0.000 claims abstract description 47
- 230000001077 hypotensive effect Effects 0.000 claims abstract description 44
- 208000001953 Hypotension Diseases 0.000 claims abstract description 41
- 208000021822 hypotensive Diseases 0.000 claims abstract description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 36
- 230000007071 enzymatic hydrolysis Effects 0.000 claims abstract description 34
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims abstract description 34
- 102000004190 Enzymes Human genes 0.000 claims abstract description 29
- 108090000790 Enzymes Proteins 0.000 claims abstract description 29
- 239000008367 deionised water Substances 0.000 claims abstract description 27
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 27
- 239000006228 supernatant Substances 0.000 claims abstract description 22
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 19
- 238000005227 gel permeation chromatography Methods 0.000 claims abstract description 15
- 239000012153 distilled water Substances 0.000 claims abstract description 10
- 239000003480 eluent Substances 0.000 claims abstract description 7
- 108090000145 Bacillolysin Proteins 0.000 claims abstract description 6
- 108091005507 Neutral proteases Proteins 0.000 claims abstract description 6
- 102000035092 Neutral proteases Human genes 0.000 claims abstract description 6
- 230000002779 inactivation Effects 0.000 claims abstract description 6
- 239000012141 concentrate Substances 0.000 claims abstract description 5
- 230000003276 anti-hypertensive effect Effects 0.000 claims description 31
- 229940088598 enzyme Drugs 0.000 claims description 28
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 12
- 239000012528 membrane Substances 0.000 claims description 12
- 238000001556 precipitation Methods 0.000 claims description 12
- 238000005119 centrifugation Methods 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims description 8
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 claims description 7
- 239000004365 Protease Substances 0.000 claims description 6
- 108090000526 Papain Proteins 0.000 claims description 5
- 229940055729 papain Drugs 0.000 claims description 5
- 235000019834 papain Nutrition 0.000 claims description 5
- 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 claims description 4
- 108010059892 Cellulase Proteins 0.000 claims description 4
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 claims description 4
- 108010059820 Polygalacturonase Proteins 0.000 claims description 4
- 229960000583 acetic acid Drugs 0.000 claims description 4
- 108010091628 alpha 1-Antichymotrypsin Proteins 0.000 claims description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 4
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 4
- ADCOVFLJGNWWNZ-UHFFFAOYSA-N antimony trioxide Chemical compound O=[Sb]O[Sb]=O ADCOVFLJGNWWNZ-UHFFFAOYSA-N 0.000 claims description 4
- 229940106157 cellulase Drugs 0.000 claims description 4
- CEJLBZWIKQJOAT-UHFFFAOYSA-N dichloroisocyanuric acid Chemical compound ClN1C(=O)NC(=O)N(Cl)C1=O CEJLBZWIKQJOAT-UHFFFAOYSA-N 0.000 claims description 4
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 4
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 claims description 4
- 239000012362 glacial acetic acid Substances 0.000 claims description 4
- JHEFOJNPLXSWNZ-UHFFFAOYSA-N n-(4-fluorophenyl)acetamide Chemical compound CC(=O)NC1=CC=C(F)C=C1 JHEFOJNPLXSWNZ-UHFFFAOYSA-N 0.000 claims description 4
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004323 potassium nitrate Substances 0.000 claims description 4
- 235000010333 potassium nitrate Nutrition 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 241001123258 Meretrix meretrix Species 0.000 claims description 3
- SEQVSYFEKVIYCP-UHFFFAOYSA-L magnesium hypophosphite Chemical compound [Mg+2].[O-]P=O.[O-]P=O SEQVSYFEKVIYCP-UHFFFAOYSA-L 0.000 claims description 3
- 229910001381 magnesium hypophosphite Inorganic materials 0.000 claims description 3
- 102000030621 adenylate cyclase Human genes 0.000 claims description 2
- 108060000200 adenylate cyclase Proteins 0.000 claims description 2
- 241001262059 Meretrix Species 0.000 claims 1
- 239000002778 food additive Substances 0.000 claims 1
- 235000013373 food additive Nutrition 0.000 claims 1
- 235000013402 health food Nutrition 0.000 claims 1
- 238000000605 extraction Methods 0.000 abstract description 21
- 235000013305 food Nutrition 0.000 abstract description 7
- 206010020772 Hypertension Diseases 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 5
- 230000004531 blood pressure lowering effect Effects 0.000 abstract description 4
- 235000020639 clam Nutrition 0.000 description 54
- 102000004196 processed proteins & peptides Human genes 0.000 description 42
- 230000000694 effects Effects 0.000 description 26
- 230000036772 blood pressure Effects 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 238000007654 immersion Methods 0.000 description 11
- 241000237519 Bivalvia Species 0.000 description 10
- 235000019512 sardine Nutrition 0.000 description 10
- 235000015097 nutrients Nutrition 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000002791 soaking Methods 0.000 description 6
- 241000555825 Clupeidae Species 0.000 description 5
- 241001125048 Sardina Species 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 208000035404 Autolysis Diseases 0.000 description 4
- 206010057248 Cell death Diseases 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000028043 self proteolysis Effects 0.000 description 4
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 3
- 239000002220 antihypertensive agent Substances 0.000 description 3
- 229940127088 antihypertensive drug Drugs 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 102000004317 Lyases Human genes 0.000 description 2
- 108090000856 Lyases Proteins 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical group C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 101000984728 Chiropsoides quadrigatus Angiotensin-converting enzyme inhibitory peptide Proteins 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 108010007859 Lisinopril Proteins 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229960002394 lisinopril Drugs 0.000 description 1
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229960002582 perindopril Drugs 0.000 description 1
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Water Supply & Treatment (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供一种文蛤降血压肽的制备方法及应用,步骤如下:预处理:将文蛤去壳取肉放入去离子水浸泡,捞出沥干,匀浆,加入蒸馏水和盐酸溶液调节pH;酶解:加文蛤肉1.1~1.5%重量份的中性蛋白酶进行酶解,加入文蛤肉0.15~0.3%重量份的复合酶,得文蛤肉酶解液;凝胶层析:将文蛤肉酶解液进行酶灭活,离心,取上清液,加入文蛤肉1~3%重量份析出剂,静置,超滤,凝胶层析,得文蛤降血压肽浓缩液;冻干保存。本发明制备工艺简单,预处理时间短,酶解液中降血压肽含量高,提高降血压肽含量和提取率,提取到的降血压肽在具有降血压功效的药物和食品中应用。The invention provides a preparation method and application of a clam hypotensive peptide, the steps are as follows: pretreatment: shell the clam and take the meat and soak it in deionized water, remove and drain, homogenate, add distilled water and hydrochloric acid solution to adjust the pH; Enzymolysis: add 1.1-1.5% by weight of clam meat for enzymolysis with neutral protease, add 0.15-0.3% by weight of clam meat to obtain clam meat enzymatic hydrolysis solution; gel chromatography: enzymatically hydrolyze clam meat The solution was subjected to enzyme inactivation, centrifuged, and the supernatant was taken, and 1-3% by weight of clam meat was added to the eluent, left to stand, ultrafiltration, and gel chromatography to obtain clam hypotensive peptide concentrate; freeze-dried and stored. The invention has simple preparation process, short pretreatment time, high blood pressure-lowering peptide content in the enzymatic hydrolysis solution, high blood-pressure-lowering peptide content and extraction rate, and the extracted blood-pressure-lowering peptide can be used in medicine and food with blood pressure-lowering effect.
Description
技术领域technical field
本发明属于生物技术及功能保健领域,具体涉及一种文蛤降血压肽的制备方法及应用。The invention belongs to the field of biotechnology and functional health care, and in particular relates to a preparation method and application of a clam hypotensive peptide.
背景技术Background technique
高血压是一种常见的心血管疾病,它不仅患病率高,而且常引起严重的心、脑、肾等其他疾病,是脑卒中、冠心病、心力衰竭和肾脏疾病主要的危险因素。目前化学合成的降压药物,如赖诺普利 (Lisinopril),培哚普利 (Perindopril),虽然治疗高血压的效果非常明显,但是长期服用易引起皮疹、蛋白尿等不良反应。Hypertension is a common cardiovascular disease. It not only has a high prevalence rate, but also often causes serious heart, brain, kidney and other diseases. It is a major risk factor for stroke, coronary heart disease, heart failure and kidney disease. Although the current chemically synthesized antihypertensive drugs, such as Lisinopril and Perindopril, have obvious effects in treating hypertension, long-term use can easily cause adverse reactions such as skin rash and proteinuria.
降血压肽,又称为血管紧张素转化酶(Angioensin I Converting Enzyme,简称ACE)抑制肽,是从食物蛋白中分离出的一类具有显著降低血压功效的多肽短链物质。从来源上,可分为乳蛋白(包括酪蛋白、乳清蛋白)、发酵食品、动物蛋白、植物蛋白以及天然ACE抑制肽。这些来源于食品的降血压肽通常由蛋白酶在温和条件下水解蛋白质而获得,食用安全性高,其共同突出优点是只对高血压患者起到降压作用,对血压正常者无降压作用,因而不会有降压过度现象发生。除降压功能,它们往往具有免疫促进、抗凝血、易消化吸收和抗肿瘤等功能。Antihypertensive peptides, also known as angiotensin converting enzyme (Angiotensin I Converting Enzyme, ACE) inhibitory peptides, are a class of polypeptide short-chain substances isolated from food proteins that can significantly lower blood pressure. From the source, it can be divided into milk protein (including casein, whey protein), fermented food, animal protein, vegetable protein and natural ACE inhibitory peptide. These antihypertensive peptides derived from food are usually obtained by protease hydrolyzing protein under mild conditions, and are safe to eat. Their common outstanding advantage is that they only have a hypotensive effect on hypertensive patients, and have no antihypertensive effect on normal blood pressure. Therefore, there will be no excessive pressure reduction. In addition to the function of lowering blood pressure, they often have functions such as immune promotion, anticoagulation, easy digestion and absorption, and antitumor.
现有技术提供多种从生物中提取降血压肽的方法及应用,例如,中国发明专利文献 一种沙丁鱼降血压肽及其制备方法与应用 授权公告号CN 104031967 B该发明属于食品生物技术及功能保健领域,公开一种沙丁鱼降血压肽及其制备方法与应用。所述方法主要技术步骤如下:沙丁鱼预处理成均浆后,先加入木瓜蛋白酶进行酶解,再加入碱性蛋白酶进行酶解;酶解完成后灭酶,并对灭酶后的酶解液进行离心;取离心后的上清液,利用超滤、凝胶层析的方法,对粗制品进行分离纯化;对分离纯化后的高效组分进行冷冻干燥,得到沙丁鱼降血压肽。沙丁鱼产量高、价格低廉,因此以沙丁鱼作为原料制备降血压肽,能充分提高沙丁鱼的综合利用价值,并且通过酶解获得的沙丁鱼降血压肽,不存在安全性问题,没有化学降血压类药物的副作用,降压效果理想。The existing technology provides a variety of methods and applications for extracting blood pressure-lowering peptides from organisms. For example, the Chinese invention patent document A sardine blood-lowering peptide and its preparation method and application authorization announcement number CN 104031967 B This invention belongs to food biotechnology and functions In the field of health care, a sardine hypotensive peptide and its preparation method and application are disclosed. The main technical steps of the method are as follows: after the sardines are pretreated into a homogenate, first add papain for enzymolysis, then add alkaline protease for enzymolysis; Centrifuging; taking the centrifuged supernatant, using ultrafiltration and gel chromatography to separate and purify the crude product; freeze-drying the separated and purified high-efficiency components to obtain the sardine hypotensive peptide. The yield of sardines is high and the price is low. Therefore, using sardines as raw materials to prepare hypotensive peptides can fully improve the comprehensive utilization value of sardines, and the sardine hypotensive peptides obtained by enzymatic hydrolysis have no safety problems and no chemical antihypertensive drugs. Side effects, antihypertensive effect ideal.
现有技术通过酶解获得沙丁鱼降血压肽,没有化学降血压药物的副作用而且提高了沙丁鱼的综合利用价值,但预处理时间过长,进行了二步酶解,取得上清液后未作提高降血压肽析出的步骤,酶解效果和提取效果有待提升,获得的降血压肽含量有待提高。In the prior art, sardine hypotensive peptides are obtained by enzymatic hydrolysis, which has no side effects of chemical antihypertensive drugs and improves the comprehensive utilization value of sardines. However, the pretreatment time is too long, and two-step enzymatic hydrolysis is performed, and no improvement is made after obtaining the supernatant. The steps of precipitation of hypotensive peptides, enzymatic hydrolysis and extraction effects need to be improved, and the content of hypotensive peptides obtained needs to be improved.
发明内容Contents of the invention
本发明针对上述技术问题提供一种预处理时间短,酶解液中降血压肽含量高,提高降血压肽提取率的一种文蛤降血压肽的制备方法及应用。Aiming at the above technical problems, the present invention provides a preparation method and application of a clam hypotensive peptide with short pretreatment time, high content of hypotensive peptide in enzymatic hydrolysis solution, and improved extraction rate of hypotensive peptide.
本发明针对上述技术问题所采取的方案为:一种文蛤降血压肽的制备方法,制备步骤如下:The solution adopted by the present invention for the above-mentioned technical problems is: a preparation method of clam hypotensive peptide, the preparation steps are as follows:
1)预处理:将文蛤去壳取肉放入去离子水浸泡8~12h,捞出沥干,匀浆,加入文蛤肉体积的3~6倍蒸馏水和盐酸溶液调节pH至6.5~8.5;通过去离子水浸泡将文蛤中的杂质、细菌及盐分清除,采用的去离子水可缩短浸泡时间进而缩短提取时间,而且取得很好的浸泡效果,加入的蒸馏水配合盐酸溶液快速调节文蛤肉的pH至指定范围,为酶解作准备,通过制备的去离子水和盐酸溶液明显的缩短预处理时间,而且预处理效果优异。1) Pretreatment: remove the clams and take the meat and soak them in deionized water for 8-12 hours, remove and drain, homogenate, add distilled water 3-6 times the volume of clam meat and hydrochloric acid solution to adjust the pH to 6.5-8.5; Soak in deionized water to remove impurities, bacteria and salt in the clam. The deionized water used can shorten the soaking time and thus the extraction time, and achieve a good soaking effect. The added distilled water and hydrochloric acid solution quickly adjust the pH of the clam meat to The specified range is prepared for enzymatic hydrolysis, and the pretreatment time is obviously shortened by the prepared deionized water and hydrochloric acid solution, and the pretreatment effect is excellent.
2)酶解:加入文蛤肉1.1~1.5%重量份的中性蛋白酶在40~50℃条件下酶解1~2h,加入文蛤肉0.15~0.3%重量份的复合酶在40~50℃条件下酶解1~3h,得文蛤肉酶解液;常规的一次酶解受限于加入酶的专一作用,降血压肽的得率不太理想,采用两次酶解及复合酶的方式可显著提高降血压肽的得率,还可以保证文蛤肉中其他的营养成分不损失,酶解的时间缩短但效果显著提升,还节省了酶的用量,可有效的节约成本。2) Enzymolysis: adding 1.1-1.5% by weight of clam meat with neutral protease at 40-50°C for 1-2 hours, adding 0.15-0.3% by weight of clam meat with compound enzyme at 40-50°C Enzymatic hydrolysis for 1~3 hours, the enzymatic hydrolyzate of clam meat is obtained; the conventional one-time enzymatic hydrolysis is limited by the specific effect of the added enzyme, and the yield of blood pressure-lowering peptide is not ideal, and the method of two enzymatic hydrolysis and compound enzyme can significantly Improving the yield of hypotensive peptides can also ensure that other nutrients in clam meat are not lost, the enzymatic hydrolysis time is shortened but the effect is significantly improved, and the amount of enzymes is also saved, which can effectively save costs.
3)凝胶层析:将文蛤肉酶解液进行酶灭活,酶灭活温度为90~95℃,时间为5~10min,采用离心机进行离心,离心转速3000~5000r/min,离心时间5~15min,取上清液,加入文蛤肉1~3%重量份析出剂,静置,采用超滤膜对加入析出剂后静置的上清液进行分离纯化,超滤膜为截留分子量为3000~10000Da的超滤膜,凝胶层析,得文蛤降血压肽浓缩液;将酶灭活使蛋白质和降血压肽聚集沉淀,为离心作准备,离心后取得的上清液中加入析出剂,在上清液中可能存在部分降血压肽未被提取出来,使用析出剂将这部分降血压肽充分提取出来,提高降血压肽的提取率,再采用超滤和凝胶层析技术获得高纯度的降血压肽,而且不需要加任何化学试剂和不会引起温度、pH的变化,因而不会影响降血压肽的纯度,可防止降血压肽失活、自溶等问题。3) Gel chromatography: deactivate the clam meat enzymatic hydrolyzate at a temperature of 90-95°C for 5-10 minutes, and centrifuge with a centrifuge at a speed of 3000-5000r/min. 5 ~ 15min, get the supernatant, add clam meat 1 ~ 3% by weight precipitation agent, leave standstill, adopt ultrafiltration membrane to separate and purify the supernatant after adding the precipitation agent, the ultrafiltration membrane is that the molecular weight cut off is 3000~10000Da ultrafiltration membrane, gel chromatography, to obtain clam hypotensive peptide concentrate; inactivate the enzyme to make protein and hypotensive peptide aggregate and precipitate, prepare for centrifugation, add precipitation agent to the supernatant obtained after centrifugation , there may be some antihypertensive peptides in the supernatant that have not been extracted. Use a precipitant to fully extract this part of antihypertensive peptides to increase the extraction rate of antihypertensive peptides, and then use ultrafiltration and gel chromatography to obtain high The pure antihypertensive peptide does not need to add any chemical reagents and will not cause changes in temperature and pH, so it will not affect the purity of the antihypertensive peptide, and can prevent the inactivation and autolysis of the antihypertensive peptide.
4)冻干保存。采用的冻干保存是一种使降血压肽在低温低压下脱水的干燥工艺,与其他干燥方法相比,具有降血压肽不变质、易长期储存、脱水彻底、挥发成分损失少等优点。4) Freeze-dried and stored. The freeze-drying method used is a drying process that dehydrates the blood pressure-lowering peptide at low temperature and low pressure. Compared with other drying methods, it has the advantages of no deterioration of the blood-pressure-lowering peptide, easy long-term storage, complete dehydration, and less loss of volatile components.
步骤2中复合酶由以下成分及重量份组成:木瓜蛋白酶10~15份、纤维素酶3~8份、果胶酶1~4份、α1-抗糜蛋白酶1~2份和腺苷酸环化酶0.3~1份和γ-谷氨酰转移酶0.5~0.8份。可显著提高降血压肽的得率,还可以保证文蛤肉中其他的营养成分不损失,酶解的时间缩短但效果显著提升,还节省了酶的用量,可有效的节约成本。The compound enzyme in step 2 is composed of the following components and parts by weight: 10-15 parts of papain, 3-8 parts of cellulase, 1-4 parts of pectinase, 1-2 parts of α1-antichymotrypsin and adenylate ring Lyase 0.3~1 part and γ-glutamyl transferase 0.5~0.8 part. It can significantly increase the yield of blood pressure-lowering peptides, and can also ensure that other nutrients in clam meat are not lost, the enzymatic hydrolysis time is shortened but the effect is significantly improved, and the amount of enzymes is also saved, which can effectively save costs.
步骤1中去离子水中含有冰醋酸0.9~1.1份、乙醇0.9~1.1份、硫酸化油1.8~2.2份、4-氟乙酰苯胺1~2份和硝酸正丙酯0.3~0.7份。通过去离子水浸泡将文蛤中的杂质、细菌及盐分清除,采用的去离子水可缩短浸泡时间进而缩短提取时间,而且取得很好的浸泡效果。The deionized water in step 1 contains 0.9-1.1 parts of glacial acetic acid, 0.9-1.1 parts of ethanol, 1.8-2.2 parts of sulfated oil, 1-2 parts of 4-fluoroacetanilide and 0.3-0.7 parts of n-propyl nitrate. The impurities, bacteria and salt in clams are removed by immersion in deionized water. The deionized water used can shorten the immersion time and thus the extraction time, and achieve a good immersion effect.
步骤2中盐酸溶液添加有氢氧化钠2~5重量份和3-乙氧基-4-羟基苯甲醛1~3重量份。快速调节文蛤肉的pH至指定范围,为酶解作准备,节约提取时间。In step 2, the hydrochloric acid solution is added with 2-5 parts by weight of sodium hydroxide and 1-3 parts by weight of 3-ethoxy-4-hydroxybenzaldehyde. Quickly adjust the pH of clam meat to the specified range to prepare for enzymatic hydrolysis and save extraction time.
步骤3中析出剂由以下成分及重量份组成:硫酸铵3~5份、氯化钠1~3份、硝酸钾0.5~1份、季戊四醇0.2~0.4份、二氯异氰尿酸钠0.05~0.1份和次磷酸镁0.7~0.8份。在上清液中可能存在部分降血压肽未被提取出来,使用析出剂将这部分降血压肽充分提取出来,且上述组合物起到了一定的活性保持效果,间接提高了降血压肽的提取率。In step 3, the precipitation agent is composed of the following components and parts by weight: 3 to 5 parts of ammonium sulfate, 1 to 3 parts of sodium chloride, 0.5 to 1 part of potassium nitrate, 0.2 to 0.4 parts of pentaerythritol, and 0.05 to 0.1 parts of sodium dichloroisocyanurate parts and 0.7~0.8 parts of magnesium hypophosphite. There may be some antihypertensive peptides in the supernatant that have not been extracted, and the eluting agent is used to fully extract this part of the antihypertensive peptides, and the above composition has a certain activity retention effect, which indirectly increases the extraction rate of the antihypertensive peptides .
通过从文蛤中提取降血压肽的方法得到的文蛤降血压肽在制备具有降血压功效的药物和食品中应用。The clam blood pressure lowering peptide obtained by extracting the blood pressure lowering peptide from clams is used in the preparation of medicines and foods with blood pressure lowering effects.
与现有技术相比,本法的优点在于:采用的去离子水可缩短浸泡时间进而缩短提取时间,而且取得很好的浸泡效果,加入的蒸馏水配合盐酸溶液快速调节文蛤肉的pH至指定范围,通过制备的去离子水和盐酸溶液明显的缩短预处理时间,而且预处理效果优异。采用两次酶解及复合酶的方式可显著提高降血压肽的得率,还可以保证文蛤肉中其他的营养成分不损失,酶解的时间缩短但效果显著提升,还节省了酶的用量,可有效的节约成本。离心后取得的上清液中加入析出剂,在上清液中可能存在部分降血压肽未被提取出来,使用析出剂将这部分降血压肽充分提取出来,提高降血压肽的提取率,再采用超滤和凝胶层析技术获得高纯度的降血压肽,而且不需要加任何化学试剂和不会引起温度、pH的变化,因而不会影响降血压肽的纯度,可防止降血压肽失活、自溶等问题。本发明制备工艺简单,预处理时间短,酶解液中降血压肽含量高,提高降血压肽含量和提取率,提取到的降血压肽在具有降血压功效的药物和食品中应用,降血压肽食用安全性高,对高血压患者起到降压作用,对血压正常者无降压作用,不会有降压过渡现象。Compared with the prior art, the advantage of this method is that the deionized water used can shorten the immersion time and thus the extraction time, and achieve a good immersion effect, and the added distilled water cooperates with the hydrochloric acid solution to quickly adjust the pH of clam meat to a specified range , the pretreatment time is obviously shortened by the prepared deionized water and hydrochloric acid solution, and the pretreatment effect is excellent. Using two enzymatic hydrolysis and compound enzyme method can significantly increase the yield of hypotensive peptides, and can also ensure that other nutrients in Meretrix meretrix are not lost, the enzymatic hydrolysis time is shortened but the effect is significantly improved, and the amount of enzymes is also saved. Can effectively save costs. Add an eluent to the supernatant obtained after centrifugation, and there may be some blood pressure-lowering peptides in the supernatant that have not been extracted. Use the eluent to fully extract this part of the blood-pressure-lowering peptide to increase the extraction rate of the blood-pressure-lowering peptide. Using ultrafiltration and gel chromatography to obtain high-purity blood pressure-lowering peptides, and does not need to add any chemical reagents and will not cause changes in temperature and pH, so it will not affect the purity of blood-pressure-lowering peptides and prevent blood-pressure-lowering peptides from losing Living, autolysis and other issues. The preparation process of the present invention is simple, the pretreatment time is short, the content of hypotensive peptide in the enzymatic hydrolysis solution is high, the content and extraction rate of hypotensive peptide are improved, and the extracted hypotensive peptide can be used in medicines and foods with hypotensive effect, which can reduce blood pressure Peptides are safe to eat, and can lower blood pressure for hypertensive patients, but have no antihypertensive effect for normal blood pressure patients, and there will be no transitional phenomenon of lowering blood pressure.
具体实施例specific embodiment
以下结合具体实施例作进一步详细描述:Describe in further detail below in conjunction with specific embodiment:
实施例1:Example 1:
一种文蛤降血压肽的制备方法,制备步骤如下:A preparation method of clam hypotensive peptide, the preparation steps are as follows:
1)预处理:将文蛤去壳取肉放入去离子水浸泡8~12h,捞出沥干,匀浆,加入文蛤肉体积的3~6倍蒸馏水和盐酸溶液调节pH至6.5~8.5;通过去离子水浸泡将文蛤中的杂质、细菌及盐分清除,采用的去离子水可缩短浸泡时间进而缩短提取时间,而且取得很好的浸泡效果,加入的蒸馏水配合盐酸溶液快速调节文蛤肉的pH至指定范围,为酶解作准备,通过制备的去离子水和盐酸溶液明显的缩短预处理时间,而且预处理效果优异。1) Pretreatment: remove the clams and take the meat and soak them in deionized water for 8-12 hours, remove and drain, homogenate, add distilled water 3-6 times the volume of clam meat and hydrochloric acid solution to adjust the pH to 6.5-8.5; Soak in deionized water to remove impurities, bacteria and salt in the clam. The deionized water used can shorten the soaking time and thus the extraction time, and achieve a good soaking effect. The added distilled water and hydrochloric acid solution quickly adjust the pH of the clam meat to The specified range is prepared for enzymatic hydrolysis, and the pretreatment time is obviously shortened by the prepared deionized water and hydrochloric acid solution, and the pretreatment effect is excellent.
2)酶解:加入文蛤肉1.1~1.5%重量份的中性蛋白酶在40~50℃条件下酶解1~2h,加入文蛤肉0.15~0.3%重量份的复合酶在40~50℃条件下酶解1~3h,得文蛤肉酶解液;常规的一次酶解受限于加入酶的专一作用,降血压肽的得率不太理想,采用两次酶解及复合酶的方式可显著提高降血压肽的得率,还可以保证文蛤肉中其他的营养成分不损失,酶解的时间缩短但效果显著提升,还节省了酶的用量,可有效的节约成本。2) Enzymolysis: adding 1.1-1.5% by weight of clam meat with neutral protease at 40-50°C for 1-2 hours, adding 0.15-0.3% by weight of clam meat with compound enzyme at 40-50°C Enzymatic hydrolysis for 1~3 hours, the enzymatic hydrolyzate of clam meat is obtained; the conventional one-time enzymatic hydrolysis is limited by the specific effect of the added enzyme, and the yield of blood pressure-lowering peptide is not ideal, and the method of two enzymatic hydrolysis and compound enzyme can significantly Improving the yield of hypotensive peptides can also ensure that other nutrients in clam meat are not lost, the enzymatic hydrolysis time is shortened but the effect is significantly improved, and the amount of enzymes is also saved, which can effectively save costs.
3)凝胶层析:将文蛤肉酶解液进行酶灭活,酶灭活温度为90~95℃,时间为5~10min,采用离心机进行离心,离心转速3000~5000r/min,离心时间5~15min,取上清液,加入文蛤肉1~3%重量份析出剂,静置,采用超滤膜对加入析出剂后静置的上清液进行分离纯化,超滤膜为截留分子量为3000~10000Da的超滤膜,凝胶层析,得文蛤降血压肽浓缩液;将酶灭活使蛋白质和降血压肽聚集沉淀,为离心作准备,离心后取得的上清液中加入析出剂,在上清液中可能存在部分降血压肽未被提取出来,使用析出剂将这部分降血压肽充分提取出来,提高降血压肽的提取率,再采用超滤和凝胶层析技术获得高纯度的降血压肽,而且不需要加任何化学试剂和不会引起温度、pH的变化,因而不会影响降血压肽的纯度,可防止降血压肽失活、自溶等问题。3) Gel chromatography: deactivate the clam meat enzymatic hydrolyzate at a temperature of 90-95°C for 5-10 minutes, and centrifuge with a centrifuge at a speed of 3000-5000r/min. 5 ~ 15min, get the supernatant, add clam meat 1 ~ 3% by weight precipitation agent, leave standstill, adopt ultrafiltration membrane to separate and purify the supernatant after adding the precipitation agent, the ultrafiltration membrane is that the molecular weight cut off is 3000~10000Da ultrafiltration membrane, gel chromatography, to obtain clam hypotensive peptide concentrate; inactivate the enzyme to make protein and hypotensive peptide aggregate and precipitate, prepare for centrifugation, add precipitation agent to the supernatant obtained after centrifugation , there may be some antihypertensive peptides in the supernatant that have not been extracted. Use a precipitant to fully extract this part of antihypertensive peptides to increase the extraction rate of antihypertensive peptides, and then use ultrafiltration and gel chromatography to obtain high The pure antihypertensive peptide does not need to add any chemical reagents and will not cause changes in temperature and pH, so it will not affect the purity of the antihypertensive peptide, and can prevent the inactivation and autolysis of the antihypertensive peptide.
4)冻干保存。采用的冻干保存是一种使降血压肽在低温低压下脱水的干燥工艺,与其他干燥方法相比,具有降血压肽不变质、易长期储存、脱水彻底、挥发成分损失少等优点。4) Freeze-dried and stored. The freeze-drying method used is a drying process that dehydrates the blood pressure-lowering peptide at low temperature and low pressure. Compared with other drying methods, it has the advantages of no deterioration of the blood-pressure-lowering peptide, easy long-term storage, complete dehydration, and less loss of volatile components.
步骤2中复合酶由以下成分及重量份组成:木瓜蛋白酶10~15份、纤维素酶3~8份、果胶酶1~4份、α1-抗糜蛋白酶1~2份和腺苷酸环化酶0.3~1份和γ-谷氨酰转移酶0.5~0.8份。可显著提高降血压肽的得率,还可以保证文蛤肉中其他的营养成分不损失,酶解的时间缩短但效果显著提升,还节省了酶的用量,可有效的节约成本。The compound enzyme in step 2 is composed of the following components and parts by weight: 10-15 parts of papain, 3-8 parts of cellulase, 1-4 parts of pectinase, 1-2 parts of α1-antichymotrypsin and adenylate ring Lyase 0.3~1 part and γ-glutamyl transferase 0.5~0.8 part. It can significantly increase the yield of blood pressure-lowering peptides, and can also ensure that other nutrients in clam meat are not lost, the enzymatic hydrolysis time is shortened but the effect is significantly improved, and the amount of enzymes is also saved, which can effectively save costs.
步骤1中去离子水中含有冰醋酸0.9~1.1份、乙醇0.9~1.1份、硫酸化油1.8~2.2份、4-氟乙酰苯胺1~2份和硝酸正丙酯0.3~0.7份。通过去离子水浸泡将文蛤中的杂质、细菌及盐分清除,采用的去离子水可缩短浸泡时间进而缩短提取时间,而且取得很好的浸泡效果。The deionized water in step 1 contains 0.9-1.1 parts of glacial acetic acid, 0.9-1.1 parts of ethanol, 1.8-2.2 parts of sulfated oil, 1-2 parts of 4-fluoroacetanilide and 0.3-0.7 parts of n-propyl nitrate. The impurities, bacteria and salt in clams are removed by immersion in deionized water. The deionized water used can shorten the immersion time and thus the extraction time, and achieve a good immersion effect.
步骤2中盐酸溶液添加有氢氧化钠2~5重量份和3-乙氧基-4-羟基苯甲醛1~3重量份。快速调节文蛤肉的pH至指定范围,为酶解作准备,节约提取时间。In step 2, the hydrochloric acid solution is added with 2-5 parts by weight of sodium hydroxide and 1-3 parts by weight of 3-ethoxy-4-hydroxybenzaldehyde. Quickly adjust the pH of clam meat to the specified range to prepare for enzymatic hydrolysis and save extraction time.
步骤3中析出剂由以下成分及重量份组成:硫酸铵3~5份、氯化钠1~3份、硝酸钾0.5~1份、季戊四醇0.2~0.4份、二氯异氰尿酸钠0.05~0.1份和次磷酸镁0.7~0.8份。在上清液中可能存在部分降血压肽未被提取出来,使用析出剂将这部分降血压肽充分提取出来,提高降血压肽的提取率。In step 3, the precipitation agent is composed of the following components and parts by weight: 3 to 5 parts of ammonium sulfate, 1 to 3 parts of sodium chloride, 0.5 to 1 part of potassium nitrate, 0.2 to 0.4 parts of pentaerythritol, and 0.05 to 0.1 parts of sodium dichloroisocyanurate parts and 0.7~0.8 parts of magnesium hypophosphite. There may be some antihypertensive peptides in the supernatant that have not been extracted, and the eluting agent is used to fully extract this part of the antihypertensive peptides to increase the extraction rate of the antihypertensive peptides.
通过从文蛤中提取降血压肽的方法得到的文蛤降血压肽在制备具有降血压功效的药物和食品中应用。The clam blood pressure lowering peptide obtained by extracting the blood pressure lowering peptide from clams is used in the preparation of medicines and foods with blood pressure lowering effects.
实施例2:Example 2:
一种文蛤降血压肽的制备方法,优选制备步骤如下:A method for preparing clam hypotensive peptide, the preferred preparation steps are as follows:
1)预处理:将文蛤去壳取肉放入去离子水浸泡,优选时间为12h,捞出沥干,匀浆,加入优选文蛤肉体积的5倍蒸馏水和盐酸溶液优选调节pH至7;通过去离子水浸泡将文蛤中的杂质、细菌及盐分清除,采用的去离子水可缩短浸泡时间进而缩短提取时间,而且取得很好的浸泡效果,加入的蒸馏水配合盐酸溶液快速调节文蛤肉的pH至指定范围,为酶解作准备,通过制备的去离子水和盐酸溶液明显的缩短预处理时间,而且预处理效果优异。1) Pretreatment: Remove the shells and take the meat of clams and soak them in deionized water for 12 hours, remove and drain, homogenate, add distilled water and hydrochloric acid solution preferably 5 times the volume of clams meat to adjust the pH to 7; Soak in deionized water to remove impurities, bacteria and salt in the clam. The deionized water used can shorten the soaking time and thus the extraction time, and achieve a good soaking effect. The added distilled water and hydrochloric acid solution quickly adjust the pH of the clam meat to The specified range is prepared for enzymatic hydrolysis, and the pretreatment time is obviously shortened by the prepared deionized water and hydrochloric acid solution, and the pretreatment effect is excellent.
2)酶解:加入优选文蛤肉1.1%重量份的优选中性蛋白酶在45℃条件下优选酶解2h,加入优选文蛤肉0.18%重量份的复合酶在优选45℃条件下优选酶解1h,得文蛤肉酶解液;常规的一次酶解受限于加入酶的专一作用,降血压肽的得率不太理想,采用两次酶解及复合酶的方式可显著提高降血压肽的得率,还可以保证文蛤肉中其他的营养成分不损失,酶解的时间缩短但效果显著提升,还节省了酶的用量,可有效的节约成本。2) Enzymolysis: adding preferred neutral protease at 1.1% by weight of preferred clam meat for optimal enzymolysis at 45°C for 2 hours, adding preferred compound enzyme with preferred clam meat at 0.18% by weight for optimal enzymolysis at 45°C for 1 hour, Obtain clam meat enzymatic hydrolysis solution; conventional one-time enzymatic hydrolysis is limited by the specific effect of adding enzymes, and the yield of hypotensive peptides is not ideal, and the method of two enzymatic hydrolysis and compound enzymes can significantly increase the yield of hypotensive peptides The efficiency can also ensure that other nutrients in the clam meat are not lost, the enzymatic hydrolysis time is shortened but the effect is significantly improved, and the amount of enzymes is also saved, which can effectively save costs.
3)凝胶层析:将文蛤肉酶解液进行酶灭活,酶灭活温度优选为92℃,时间优选为6min,采用离心机进行离心,优选离心转速4000r/min,离心时间优选10min,取上清液,加入优选文蛤肉2%重量份析出剂,静置,采用超滤膜对加入析出剂后静置的上清液进行分离纯化,超滤膜为截留分子量优选为7000Da的超滤膜,凝胶层析,得文蛤降血压肽浓缩液;将酶灭活使蛋白质和降血压肽聚集沉淀,为离心作准备,离心后取得的上清液中加入析出剂,在上清液中可能存在部分降血压肽未被提取出来,使用析出剂将这部分降血压肽充分提取出来,提高降血压肽的提取率,再采用超滤和凝胶层析技术获得高纯度的降血压肽,而且不需要加任何化学试剂和不会引起温度、pH的变化,因而不会影响降血压肽的纯度,可防止降血压肽失活、自溶等问题。3) Gel chromatography: deactivate the clam meat enzymatic hydrolyzate, the enzyme inactivation temperature is preferably 92°C, the time is preferably 6min, and centrifuged with a centrifuge, preferably the centrifugal speed is 4000r/min, and the centrifugation time is preferably 10min, Get the supernatant, add preferred clam meat 2% weight part precipitation agent, leave standstill, adopt the ultrafiltration membrane to separate and purify the supernatant after adding the precipitation agent, and the ultrafiltration membrane is preferably an ultrafiltration with a molecular weight cut-off of 7000Da Membrane, gel chromatography, to obtain clam hypotensive peptide concentrate; inactivate the enzyme to make protein and hypotensive peptide aggregate and precipitate, prepare for centrifugation, add eluent to the supernatant obtained after centrifugation, and add eluent to the supernatant There may be some antihypertensive peptides that have not been extracted. Use the eluent to fully extract this part of the antihypertensive peptides to increase the extraction rate of the antihypertensive peptides, and then use ultrafiltration and gel chromatography to obtain high-purity antihypertensive peptides. Moreover, it does not need to add any chemical reagents and will not cause changes in temperature and pH, so the purity of the hypotensive peptide will not be affected, and problems such as inactivation and autolysis of the hypotensive peptide can be prevented.
4)冻干保存。采用的冻干保存是一种使降血压肽在低温低压下脱水的干燥工艺,与其他干燥方法相比,具有降血压肽不变质、易长期储存、脱水彻底、挥发成分损失少等优点。4) Freeze-dried and stored. The freeze-drying method used is a drying process that dehydrates the blood pressure-lowering peptide at low temperature and low pressure. Compared with other drying methods, it has the advantages of no deterioration of the blood-pressure-lowering peptide, easy long-term storage, complete dehydration, and less loss of volatile components.
步骤2中复合酶由以下成分及优选重量份组成:优选木瓜蛋白酶13份、优选纤维素酶7份、优选果胶酶3份、优选α1-抗糜蛋白酶1份和优选腺苷酸环化酶0.5份和优选γ-谷氨酰转移酶0.6份。可显著提高降血压肽的得率,还可以保证文蛤肉中其他的营养成分不损失,酶解的时间缩短但效果显著提升,还节省了酶的用量,可有效的节约成本。The compound enzyme in step 2 is composed of the following components and preferred parts by weight: preferably 13 parts of papain, preferably 7 parts of cellulase, preferably 3 parts of pectinase, preferably 1 part of α1-antichymotrypsin and preferably adenylate cyclase 0.5 parts and preferably 0.6 parts of gamma-glutamyltransferase. It can significantly increase the yield of blood pressure-lowering peptides, and can also ensure that other nutrients in clam meat are not lost, the enzymatic hydrolysis time is shortened but the effect is significantly improved, and the amount of enzymes is also saved, which can effectively save costs.
步骤1中去离子水中含有优选冰醋酸1份、优选乙醇1份、优选硫酸化油1.9份、优选4-氟乙酰苯胺1份和优选硝酸正丙酯0.5份。通过去离子水浸泡将文蛤中的杂质、细菌及盐分清除,采用的去离子水可缩短浸泡时间进而缩短提取时间,而且取得很好的浸泡效果。The deionized water in step 1 contains preferably 1 part of glacial acetic acid, preferably 1 part of ethanol, preferably 1.9 parts of sulfated oil, preferably 1 part of 4-fluoroacetanilide and preferably 0.5 part of n-propyl nitrate. The impurities, bacteria and salt in clams are removed by immersion in deionized water. The deionized water used can shorten the immersion time and thus the extraction time, and achieve a good immersion effect.
步骤2中盐酸溶液添加有优选氢氧化钠3重量份和优选3-乙氧基-4-羟基苯甲醛2重量份。快速调节文蛤肉的pH至指定范围,为酶解作准备,节约提取时间。In step 2, the hydrochloric acid solution is preferably added with 3 parts by weight of sodium hydroxide and 2 parts by weight of 3-ethoxy-4-hydroxybenzaldehyde. Quickly adjust the pH of clam meat to the specified range to prepare for enzymatic hydrolysis and save extraction time.
步骤3中析出剂由以下成分及优选重量份组成:优选硫酸铵4份、优选氯化钠2份、优选硝酸钾0.7份、优选季戊四醇0.3份、优选二氯异氰尿酸钠0.07份和优选次磷酸镁0.75份。在上清液中可能存在部分降血压肽未被提取出来,使用析出剂将这部分降血压肽充分提取出来,提高降血压肽的提取率。In step 3, the eluting agent is composed of the following components and preferred parts by weight: preferably 4 parts of ammonium sulfate, preferably 2 parts of sodium chloride, preferably 0.7 part of potassium nitrate, preferably 0.3 part of pentaerythritol, preferably 0.07 part of sodium dichloroisocyanurate and preferably 0.75 parts of magnesium phosphate. There may be some antihypertensive peptides in the supernatant that have not been extracted, and the eluting agent is used to fully extract this part of the antihypertensive peptides to increase the extraction rate of the antihypertensive peptides.
通过从文蛤中提取降血压肽的方法得到的文蛤降血压肽在制备具有降血压功效的药物和食品中应用。The clam blood pressure lowering peptide obtained by extracting the blood pressure lowering peptide from clams is used in the preparation of medicines and foods with blood pressure lowering effects.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围。The above-mentioned embodiment is a preferred embodiment of the present invention, but the embodiment of the present invention is not limited by the above-mentioned embodiment, and any other changes, modifications, substitutions, combinations, Simplification should be equivalent replacement methods, and all are included in the protection scope of the present invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611021249.6A CN106676153A (en) | 2016-11-21 | 2016-11-21 | Preparation method and application of meretrix lusoria blood-pressure-reducing peptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611021249.6A CN106676153A (en) | 2016-11-21 | 2016-11-21 | Preparation method and application of meretrix lusoria blood-pressure-reducing peptide |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106676153A true CN106676153A (en) | 2017-05-17 |
Family
ID=58866426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611021249.6A Pending CN106676153A (en) | 2016-11-21 | 2016-11-21 | Preparation method and application of meretrix lusoria blood-pressure-reducing peptide |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106676153A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114712400A (en) * | 2022-04-13 | 2022-07-08 | 济南瑞隆安生物技术有限公司 | Probiotic fermented clam powder composition capable of reducing blood sugar and blood pressure and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1451393A (en) * | 2002-04-19 | 2003-10-29 | 清华大学 | Clam extract, and preparing process and use thereof |
CN103242430A (en) * | 2013-05-31 | 2013-08-14 | 南京中医药大学 | Angiotensin-converting enzyme inhibitory peptide, and preparation method and application thereof |
-
2016
- 2016-11-21 CN CN201611021249.6A patent/CN106676153A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1451393A (en) * | 2002-04-19 | 2003-10-29 | 清华大学 | Clam extract, and preparing process and use thereof |
CN103242430A (en) * | 2013-05-31 | 2013-08-14 | 南京中医药大学 | Angiotensin-converting enzyme inhibitory peptide, and preparation method and application thereof |
Non-Patent Citations (1)
Title |
---|
张绵松: "酶法制备文蛤ACE抑制肽的研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114712400A (en) * | 2022-04-13 | 2022-07-08 | 济南瑞隆安生物技术有限公司 | Probiotic fermented clam powder composition capable of reducing blood sugar and blood pressure and preparation method thereof |
CN114712400B (en) * | 2022-04-13 | 2024-10-18 | 济南瑞隆安生物技术有限公司 | Probiotic fermented clam powder composition capable of reducing blood sugar and blood pressure and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104004813B (en) | A kind of preparation of mushroom biologically active peptide | |
CN103992384A (en) | Pseudosciaena crocea fish bone collagen peptide, and preparation method and application thereof | |
CN100489016C (en) | Method of extracting collagen and method of using collagen to prepare collagen protein | |
CN103255186B (en) | Combined production method for abalone polysaccharide, lipid and protein peptide | |
CN104710525B (en) | Tuna bone collagen source zinc chelated collagen peptide and preparation method and application thereof | |
CN104031967B (en) | A kind of sardine blood pressure lowering peptide and preparation method and application | |
CN103980347B (en) | Antihypertensive peptide of swim bladder of large yellow croaker and preparation method and use thereof | |
CN101709319A (en) | Method for preparing fish skin and scale collagen peptide | |
CN106967168A (en) | A kind of preparation method of collagen oligopeptide of black ginseng | |
CN101230088A (en) | Method for extracting undenatured natural collagen from animal skin or/and tendon | |
CN114214384A (en) | Marine organism-derived collagen peptide, and extraction method and application thereof | |
CN104513843A (en) | Joint preparation method of polysaccharide and protein peptide | |
CN105779542A (en) | Method for preparing organic rapeseed polypeptide through enzyme method | |
CN102477004A (en) | A method for extracting natural taurine from oysters using ultrafiltration technology | |
CN109943612B (en) | Method for producing high-activity minced fillet and product antifreeze agent by enzymolysis of silver carp scales | |
CN106720926A (en) | A kind of cod row delicate flavour peptide and preparation method thereof | |
CN102911990A (en) | Method for preparing micro-molecular hemepeptide from duck blood | |
CN103215333A (en) | Method for preparing angiotensin-I-converting enzyme (ACE) inhibitory peptide by using enzymolysis goat milk casein | |
CN104774899A (en) | Method for preparing cervical cancer resistant polypeptide from tuna dark meat protein | |
CN106676153A (en) | Preparation method and application of meretrix lusoria blood-pressure-reducing peptide | |
WO2023082523A1 (en) | Method for improving extraction rate of chondroitin sulfate prepared from tilapia skull | |
CN103320488B (en) | Method for preparing ACE (Angiotensin Converting Enzyme) inhibitory peptides through proteolysis of eucommia seed cakes | |
CN101736051B (en) | Method for preparing mercenaria mercenaria linnaeus polysaccharide | |
CN106591409A (en) | Squid ink oligopeptide with lipid metabolism regulation function | |
CN106498015A (en) | A kind of preparation method and application of Ruditapes philippinarum blood pressure lowering peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170517 |